Human Tissues, Lipoproteins, Lipidomics, and Proteomics Core for Cardiovascular Research
Official title: Human Tissues, Lipidomics, and Proteomics Core
Funded at New York University D/b/a NYU Long Island School of Medicine · NIH-11327658 · Data updated 2026-11-12
A core facility at NYU Langone/Long Island will provide human tissues and advanced lipid/proteomics analyses to support cardiovascular research across three projects.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University D/b/a NYU Long Island School of Medicine NIH-funded |
| Lab location | 1 site (Mineola, United States) |
| Project start | May 1, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $233,218 |
| NIH project number | 5P01HL160470-04 |
| Project ID | NIH-11327658 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with or at risk for ASCVD may indirectly benefit as the research advances translation from animal models to human biology.
✕Less likely to help
This core does not directly test a treatment in patients and may have limited immediate benefit to any individual patient.
What this research studies
This grant funds Core 2 to supply human tissues and analytical capabilities to the cardiovascular projects, helping translate mouse findings to human relevance. It will offer specialized lipoprotein, lipidomic, and proteomic analyses not available in-house, using advanced separation and analytical techniques. Clinical samples such as sera, liver, and adipose tissue will be provided to investigators, centralizing methods to reduce the burden on individual labs. The core aims to standardize procedures, improve data comparability, and strengthen the translational potential of the overall program.
Why it matters
Potential benefit: Patients could benefit from more precise understanding of harmful lipoprotein particles and tissue-based insights that may translate into better cardiovascular risk assessment and therapies.
How similar studies have gone: Other cardiovascular research cores have shown that centralized omics analyses accelerate discovery and improve reproducibility.
Where this research is happening
-
New York University D/b/a NYU Long Island School of Medicine
Mineola, United States Active
Researchers
- Principal investigator: Aleman, Jose Orlando — New York University D/b/a NYU Long Island School of Medicine
- Study coordinator: Aleman, Jose Orlando
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.